Scientists have now conducted a first-in-human trial with a vaccine against MERS (Middle East Respiratory Syndrome). The MVA-MERS-S vaccine was tolerated well and triggered the development of antibodies and T cell immunity.
from Health & Medicine News -- ScienceDaily https://www.sciencedaily.com/releases/2020/04/200422132600.htm
No comments:
Post a Comment